Analysis of tumor RNA carried in platelets – blood components best known for their role in clotting — may prove to be more useful than other ‘liquid biopsy’ technologies for diagnosing cancer and determining its primary location and potential therapeutic approaches.
This full article appears on <a href="http://www.sciencedaily.com/releases/2015/10/151030161342.htm">Science Daily</a>